Related Experiment Video
Updated: May 31, 2026

Topical Application Bioassay to Quantify Insecticide Toxicity for Mosquitoes and Fruit Flies
Published on: January 19, 2022
Use of threshold and mode of action in risk assessment
1Department of Mathematics and Statistics, Louisiana Tech University, Ruston, Louisiana 71272-0046, USA. KennyCrump@email.com
Abstract:
Under current guidelines, exposure guidelines for toxicants are determined by following one of two different tracks depending on whether the toxicant's mode of action (MOA) is believed to involve an exposure threshold. Although not denying the existence of thresholds, this paper points out problems with how the threshold concept and MOA is used in risk assessment. Thresholds are frequently described using imprecise terms that imply some unspecified increase in risk, which robs them of any meaning (any reasonable dose response will satisfy such a definition) and tacitly implies a value judgment about how large a risk is acceptable. MOA is generally used only to inform a threshold's existence and not its value. Often MOA is used only to conclude that the adverse effect requires an upstream cellular or biochemical response for which a threshold is simply assumed. Data to inform MOA often come from animals, which complicates evaluation of the role of human variation in genetic and environmental conditions, and the possible interaction of the toxicant with processes already producing background toxicity in humans. In response to these and other problems with the current two-track approach, this paper proposes a modified point of departure/safety factor approach to setting exposure guidelines for all toxicants. MOA and the severity of the toxic effect would be addressed using safety factors calculated from guidelines established by consensus and based on scientific judgment. The method normally would not involve quantifying low-dose risk, and would not require a threshold determination, although MOA information regarding the likelihood of a threshold could be used in setting safety factors.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Hazard Rate
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Dose Response Curve: Conventional Versus Nonmonotonic
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
